Mersana Therapeutics Inc (MRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -69,192 | -171,670 | -204,212 | -170,060 | -88,045 |
| Depreciation Amortization | -2,289 | -3,052 | -535 | 855 | 924 |
| Accounts receivable | 0 | 30,000 | -30,000 | 0 | N/A |
| Accounts payable and accrued liabilities | -2,857 | -6,080 | 947 | 483 | 942 |
| Other Working Capital | -27,622 | -15,983 | 133,099 | 10,085 | 5,105 |
| Other Operating Activity | 19,620 | -2,097 | 51,338 | 18,649 | 6,378 |
| Operating Cash Flow | $-82,340 | $-168,882 | $-49,363 | $-139,988 | $-74,696 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -132 | -2,168 | -2,197 | -648 | -473 |
| Purchase Of Investment | -133,431 | -155,919 | -247,519 | 0 | N/A |
| Sale Of Investment | 145,000 | 277,970 | 97,000 | 0 | 37,500 |
| Investing Cash Flow | $11,437 | $119,883 | $-152,716 | $-648 | $37,027 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -150 | N/A | 24,042 | -197 |
| Debt Repayment | -2,230 | -262 | -272 | -5,701 | -116 |
| Common Stock Issued | 56 | 427 | 1,331 | 1,837 | 167,128 |
| Common Stock Repurchased | 486 | 1,121 | 1,065 | 640 | 561 |
| Other Financing Activity | 5,780 | 93,539 | 150,893 | 42,828 | 63,036 |
| Financing Cash Flow | $4,092 | $94,675 | $153,017 | $63,646 | $230,412 |
| Beginning Cash Position | 175,039 | 129,363 | 178,425 | 255,415 | 62,672 |
| End Cash Position | 108,228 | 175,039 | 129,363 | 178,425 | 255,415 |
| Net Cash Flow | $-66,811 | $45,676 | $-49,062 | $-76,990 | $192,743 |
| Free Cash Flow | |||||
| Operating Cash Flow | -82,340 | -168,882 | -49,363 | -139,988 | -74,696 |
| Capital Expenditure | -132 | -2,168 | -2,197 | -648 | -473 |
| Free Cash Flow | -82,472 | -171,050 | -51,560 | -140,636 | -75,169 |